SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exagen Inc. – ‘10-K’ for 12/31/21 – ‘EX-23.1’

On:  Tuesday, 3/22/22, at 5:21pm ET   ·   For:  12/31/21   ·   Accession #:  1628280-22-6926   ·   File #:  1-39049

Previous ‘10-K’:  ‘10-K/A’ on 4/1/21 for 12/31/20   ·   Next:  ‘10-K’ on 3/20/23 for 12/31/22   ·   Latest:  ‘10-K’ on 3/18/24 for 12/31/23   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/22/22  Exagen Inc.                       10-K       12/31/21   73:8.6M                                   Workiva Inc Wde… FA01/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.16M 
 2: EX-23.1     Consent of Expert or Counsel                        HTML     20K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
11: R1          Cover                                               HTML     87K 
12: R2          Audit Information                                   HTML     26K 
13: R3          Balance Sheets                                      HTML    107K 
14: R4          Balance Sheets - (Parenthetical)                    HTML     40K 
15: R5          Statements of Operations                            HTML     82K 
16: R6          Statements of Stockholders' Equity                  HTML     80K 
17: R7          Statements of Stockholders' Equity (Parenthetical)  HTML     21K 
18: R8          Statements of Cash Flows                            HTML    114K 
19: R9          Organization                                        HTML     26K 
20: R10         Summary of Significant Accounting Policies          HTML    105K 
21: R11         Other Financial Information                         HTML     53K 
22: R12         Borrowings                                          HTML     40K 
23: R13         Commitment and Contingencies                        HTML     44K 
24: R14         Fair Value Measurements                             HTML     36K 
25: R15         Stockholders' Equity                                HTML     41K 
26: R16         Stock Option Plan                                   HTML     78K 
27: R17         Income Taxes                                        HTML     76K 
28: R18         401(k) Plan                                         HTML     26K 
29: R19         Covid-19                                            HTML     27K 
30: R20         Summary of Significant Accounting Policies -        HTML     86K 
                (Policies)                                                       
31: R21         Summary of Significant Accounting Policies -        HTML     83K 
                (Tables)                                                         
32: R22         Other Financial Information - (Tables)              HTML     56K 
33: R23         Borrowings - (Tables)                               HTML     30K 
34: R24         Commitment and Contingencies (Tables)               HTML     50K 
35: R25         Fair Value Measures and Disclosures (Tables)        HTML     35K 
36: R26         Stockholders' Equity (Tables)                       HTML     34K 
37: R27         Stock Option Plan (Tables)                          HTML     84K 
38: R28         Income Taxes (Tables)                               HTML     77K 
39: R29         Organization - (Details)                            HTML     27K 
40: R30         Summary of Significant Accounting Policies -        HTML     39K 
                Revenue by Major Payers (Details)                                
41: R31         Summary of Significant Accounting Policies -        HTML     83K 
                Narrative (Details)                                              
42: R32         Summary of Significant Accounting Policies -        HTML     36K 
                Disaggregation of Revenue (Details)                              
43: R33         Summary of Significant Accounting Policies - Cash,  HTML     29K 
                cash equivalents and restricted cash (Details)                   
44: R34         Summary of Significant Accounting Policies -        HTML     33K 
                Securities (Details)                                             
45: R35         Other Financial Information - Prepaid Expenses      HTML     32K 
                (Details)                                                        
46: R36         Other Financial Information - Property and          HTML     40K 
                Equipment (Details)                                              
47: R37         Other Financial Information - Narrative (Details)   HTML     29K 
48: R38         Other Financial Information - Accrued Liabilities   HTML     40K 
                (Details)                                                        
49: R39         Borrowings - Narrative (Details)                    HTML     58K 
50: R40         Borrowings - Future minimum payments (Details)      HTML     45K 
51: R41         Commitment and Contingencies - Narrative (Details)  HTML     68K 
52: R42         Commitment and Contingencies - Minimum annual       HTML     66K 
                lease payments under non-cancelable lease                        
                arrangements (Details)                                           
53: R43         Fair Value Measurements (Details)                   HTML     31K 
54: R44         Stockholders' Equity - Narrative (Details)          HTML     42K 
55: R45         Stockholders' Equity (Details)                      HTML     40K 
56: R46         Stock Option Plan - Narrative (Details)             HTML     68K 
57: R47         Stock Option Plan - Stock Option Activity           HTML     76K 
                (Details)                                                        
58: R48         Stock Option Plan - Restricted Stock Units          HTML     51K 
                (Details)                                                        
59: R49         Stock Option Plan - Fair Value Assumptions          HTML     45K 
                (Details)                                                        
60: R50         Stock Option Plan - Stock-Based Compensation        HTML     30K 
                Expense (Details)                                                
61: R51         Stock Option Plan - Common Stock Reserved For       HTML     33K 
                Future Issuance (Details)                                        
62: R52         Income Taxes - Components of Income Tax Expense     HTML     43K 
                (Benefit) (Details)                                              
63: R53         Income Taxes - Reconciliation of Effective Income   HTML     41K 
                Tax Rate (Details)                                               
64: R54         Income Taxes - Reconciliation of Deferred Tax       HTML     55K 
                Assets and Liabilities (Details)                                 
65: R55         Income Taxes - Change In Valuation Allowance        HTML     27K 
                (Details)                                                        
66: R56         Income Taxes - Narrative (Details)                  HTML     33K 
67: R57         401(k) Plan (Details)                               HTML     27K 
68: R58         Covid-19 (Details)                                  HTML     29K 
71: XML         IDEA XML File -- Filing Summary                      XML    128K 
69: XML         XBRL Instance -- exdx-20211231_htm                   XML   1.45M 
70: EXCEL       IDEA Workbook of Financial Reports                  XLSX     91K 
 7: EX-101.CAL  XBRL Calculations -- exdx-20211231_cal               XML    192K 
 8: EX-101.DEF  XBRL Definitions -- exdx-20211231_def                XML    518K 
 9: EX-101.LAB  XBRL Labels -- exdx-20211231_lab                     XML   1.62M 
10: EX-101.PRE  XBRL Presentations -- exdx-20211231_pre              XML    907K 
 6: EX-101.SCH  XBRL Schema -- exdx-20211231                         XSD    151K 
72: JSON        XBRL Instance as JSON Data -- MetaLinks              398±   570K 
73: ZIP         XBRL Zipped Folder -- 0001628280-22-006926-xbrl      Zip    720K 


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 23.1


Consent of Independent Registered Public Accounting Firm

Exagen Inc.
Vista, California
We hereby consent to the incorporation by reference in the Registration Statement Form S-3 (No. 333-250015) and Form S-8 (Nos. 333-233878 and 333-256014) of Exagen Inc. of our report dated March 22, 2022, relating to the financial statements, which appears in this Annual Report on Form 10-K.

/s/ BDO USA, LLP

San Diego, California
March 22, 2022






Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/22/228-K
For Period end:12/31/21
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/15/22  Exagen Inc.                       424B5                  1:579K


10 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/10/21  Exagen Inc.                       10-Q        9/30/21   67:6.8M
 8/09/21  Exagen Inc.                       10-Q        6/30/21   61:5.8M
 3/22/21  Exagen Inc.                       8-K:5,9     3/22/21    2:276K
 3/16/21  Exagen Inc.                       10-K       12/31/20   78:8.7M
11/10/20  Exagen Inc.                       10-Q        9/30/20   62:5.7M
 7/28/20  Exagen Inc.                       10-Q        6/30/20   62:6.3M
 3/25/20  Exagen Inc.                       10-K       12/31/19   88:11M
 9/23/19  Exagen Inc.                       8-K:5,8,9   9/23/19    3:227K                                   Donnelley … Solutions/FA
 9/09/19  Exagen Inc.                       S-1/A                 12:4.2M                                   Donnelley … Solutions/FA
 8/23/19  Exagen Inc.                       S-1                   51:8.5M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001628280-22-006926   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 11:21:05.3pm ET